[Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist].
Rau
R
R
Evangelisches Fachkrankenhaus Rheumatologische Klinik, Ratingen.
Sander
O
O
Musikic
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D008297:Male; D008875:Middle Aged; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors* / Q000502:physiology; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D012795:Sialoglycoproteins / Q000009:adverse effects / Q000627:therapeutic use*
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins
Behandlung der chronischen Polyarthritis mit einem humanen rekombinanten Interleukin-1-Rezeptor-Antagonisten.